drugset / Trial / NCT02377661
Lowering Blood Pressure in Primary Care in Vienna
Phase 4
Completed
229 enrolled
Wilhelminenspital Vienna
Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology · collabLudwig Boltzmann Institute for Cardiovascular Research · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this prospective, randomised, open-label, multicentre clinical trial is to enhance blood pressure control in primary care by introducing a standardised and simplified titration regime with single pill combinations (SPC), comprising an angiotensin receptor blocker, calcium channel blocker and hydrochlorothiazide.
Timeline
- Start
- 2015-03
- Primary completion
- 2017-05-30
- Completion
- 2017-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | — | — |
| Subject | Hydrochlorothiazide | Unknown | — | — |
| Subject | Olmesartan medoxomil | Unknown | — | — |